Healthcare & Life Sciences
Agomab Therapeutics
Belgiumagomab.com
Agomab Therapeutics is a series b startup. 3 investors tracked.
Activeseries-b
series-b
Stage
2018
Founded
9
Investors
About Agomab Therapeutics
Agomab Therapeutics is a startup founded in 2018 based in Belgium. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 9 investors associated with the company.
Agomab Therapeutics is a biopharmaceutical company translating the power of growth factors into novel medicines for fibrotic diseases.
Explore Agomab Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.